A cure for cancer?, page-6

Sorry to hear that Jase.

Yes just doing the same as the T cell therapies, but with no safety issues is enough. And how many $10's billions do T cell therapies make each year?

But as the patient produces their own antibodies, there's also the theory that they will be more effective and more on-demand. Also patients are less likely to build a resistance to the treatment.

The evidence so far is that B cells are looking far superior to T cell therapies. And T cell therapies are a very valuable and growing market - which B cells could wipe out in a flash.

The value of imu's product is potentially seriously big.

cheers